Real-time enrollment status for this metastatic brain disease clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 4:59 AM UTC
| NCT Number | NCT04222062 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Brain Disease |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 2 sites in the US |
| Sponsor | University of Nebraska |
| Last Updated on CT.gov | April 28, 2026 (Apr 28, 2026) |
As of July 19, 2026: Clinical trial NCT04222062 is currently recruiting participants. This phase2 study for metastatic brain disease is actively seeking new participants at 2 locations across the United States. The study is sponsored by University of Nebraska. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04222062 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04222062 was last updated Apr 28, 2026 (April 28, 2026). HelloStudys verifies this status automatically.